Major gene alterations include gene fusions of TMPRSS2 with ETS family genes [62], the amplification of MYC oncogene, the deletion and/or mutation of PTEN and TP53 tumor suppressors, and, in advanced PCa, the amplification and/or mutation of AR. This evidence concerns the gene PTEN and posterior cortical atrophy.